Correlation Analysis Between Astrazeneca PLC and GlaxoSmithKline PLC

Analyzing existing cross correlation between Astrazeneca PLC and GlaxoSmithKline PLC. You can compare the effects of market volatilities on Astrazeneca PLC and GlaxoSmithKline PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Astrazeneca PLC with a short position of GlaxoSmithKline PLC. See also your portfolio center. Please also check ongoing floating volatility patterns of Astrazeneca PLC and GlaxoSmithKline PLC.
Horizon     30 Days    Login   to change
Symbolsvs
Check Efficiency

Comparative Performance

Astrazeneca PLC  
88

Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in Astrazeneca PLC are ranked lower than 8 (%) of all global equities and portfolios over the last 30 days. Allthough quite conflicting forward indicators, Astrazeneca PLC may actually be approaching a critical reversion point that can send shares even higher in February 2020.
GlaxoSmithKline PLC  
1010

Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in GlaxoSmithKline PLC are ranked lower than 10 (%) of all global equities and portfolios over the last 30 days. Regardless of fairly conflicting technical and fundamental indicators, GlaxoSmithKline PLC may actually be approaching a critical reversion point that can send shares even higher in February 2020.

Astrazeneca PLC and GlaxoSmithKline PLC Volatility Contrast

 Predicted Return Density 
    
  Returns 

Astrazeneca PLC  vs.  GlaxoSmithKline PLC

 Performance (%) 
    
  Timeline 

Pair Volatility

Considering 30-days investment horizon, Astrazeneca PLC is expected to generate 1.04 times less return on investment than GlaxoSmithKline PLC. In addition to that, Astrazeneca PLC is 1.15 times more volatile than GlaxoSmithKline PLC. It trades about 0.13 of its total potential returns per unit of risk. GlaxoSmithKline PLC is currently generating about 0.15 per unit of volatility. If you would invest  4,402  in GlaxoSmithKline PLC on December 23, 2019 and sell it today you would earn a total of  348.00  from holding GlaxoSmithKline PLC or generate 7.91% return on investment over 30 days.

Pair Corralation between Astrazeneca PLC and GlaxoSmithKline PLC

0.93
Time Period3 Months [change]
DirectionPositive 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Diversification Opportunities for Astrazeneca PLC and GlaxoSmithKline PLC

Astrazeneca PLC diversification synergy

Almost no diversification

Overlapping area represents the amount of risk that can be diversified away by holding Astrazeneca PLC and GlaxoSmithKline PLC in the same portfolio assuming nothing else is changed. The correlation between historical prices or returns on GlaxoSmithKline PLC and Astrazeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Astrazeneca PLC are associated (or correlated) with GlaxoSmithKline PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GlaxoSmithKline PLC has no effect on the direction of Astrazeneca PLC i.e. Astrazeneca PLC and GlaxoSmithKline PLC go up and down completely randomly.
See also your portfolio center. Please also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. drill down to check world indexes.